KLK3 and cancer: The most recent European Association of Urology guidelines [5] recommend against biopsy for men with an abnormal prostate-specific antigen (PSA) and negative mpMRI findings, provided the suspected risk of aggressive cancer is low and the patient has discussed the pros and cons of forgoing biopsy with a doctor.